ClosedOpportunity HT942526OCRPIIRA

DoW, Ovarian Cancer, Investigator-Initiated Research Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW, Ovarian Cancer, Investigator-Initiated Research Award is a closed federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). The application deadline was October 1, 2026. Total estimated funding is $16.5M across about 14 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

May 4, 2026Posted
Oct 1, 2026Application deadline
Oct 31, 2026Archivednext date

Posted: May 4, 2026
Close date: Oct 1, 2026
Archive date: Oct 31, 2026
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $16,450,000
Expected awards: 14
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Who can apply

Unrestricted (any entity type)

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care.

Distinctive Features: Application must contain strong research plan with sound scientific rational and logical reasoning. Preliminary data are required. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials.

Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, will work synergistically on a single project. The results of this partnering project should significantly advance the research beyond what would be possible through individual efforts.

Assistance Listing

What is an ALN?

12.420Military Medical Research and DevelopmentProgram →

Reported obligations under ALN 12.420

Historical data · not a prediction

FY24

$1.48B

FY25

$1.2B

FY26

— est.

Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Christopher Meinberg Grantor
help@eBRAP.org
3016192657

Quick answers

Who is eligible to apply for “DoW, Ovarian Cancer, Investigator-Initiated Research Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW, Ovarian Cancer, Investigator-Initiated Research Award”?

Per the notice, total estimated program funding is $16,450,000 and the agency expects to make about 14 awards.

How do I apply for “DoW, Ovarian Cancer, Investigator-Initiated Research Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526OCRPIIRA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 14 daysALN 12.420